Biohaven reveals positive results in migrane drug trial

In this article:

Biohaven Pharmaceuticals, which recently announced a positive Stage 3 trial for one of its migraine treatments. Dr. Vlad Coric, CEO of Biohaven, discusses the future of the drug and the company with Yahoo Finance's Alexis Christoforous and Brian Sozzi

Advertisement